abstract |
the present invention relates to anti-bcma (uniab) heavy chain antibodies only and disclosed compositions, together with methods for making such antibodies, compositions, which include pharmaceutical compositions, which comprise such antibodies and their use to treat b cell disorders characterized by the expression of bcma. |